Background/Aims: On-line hemodiafiltration (HDF) is not yet routinely used in ICUs given the potential risk of microbial contamination of dialysis fluids. We evaluated the safety and the tolerance of its use in our ICU. Methods: A weekly measurement of bacterial growth (CFU/ml) and endotoxin level (endotoxin units/ml) was performed in dialysis fluids over a 7-year period. Intradialytic hypotensive events and pyrogenic reactions were collected during 466 on-line HDF sessions. Results: A bacterial count <0.1 CFU/ml was achieved in 977/978, 288/290, and 278/280, and an endotoxin level <0.03 endotoxin units/ml in 564/576, 330/337 and 318/323 ultrapure water, dialysate, and infusate samples, respectively. Seventy-six intradialytic hypotensive events but no pyrogenic reaction occurred. Conclusion: The great majority of dialysis fluid samples were considered suitable with a 99% compliance rate. Use of on-line HDF, at a large scale of dialysate and infusate flows, is well tolerated and may be safely performed in critically ill.

1.
Uchino S, Kellum JA, Bellomo R, et al: Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813–818.
2.
Lameire N, Van Biesen W, Vanholder R: Acute renal failure. Lancet 2005;365:417–30.
3.
Cruz DN, Bolgan I, Perazella MA, Bonello M, de Cal M, Corradi V, Polanco N, Ocampo C, Nalesso F, Piccinni P, Ronco C: North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI) Investigators: North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): Targeting the problem with the RIFLE Criteria. Clin J Am Soc Nephrol 2007;2:418–425.
4.
Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF: Hemodiafe Study Group: Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006;368:379–385.
5.
Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, Kaplan RM: Collaborative Group for Treatment of ARF in the ICU: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60:1154–1163.
6.
Kumar VA, Yeun JY, Depner TA, Don BR: Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs 2004;27:371–379.
7.
Kielstein JT, Kretschmer U, Ernst T, et al: Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004;43:342–349.
8.
Saudan P, Niederberger M, De Seigneux S, et al: Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006;70:1312–1317.
9.
Marshall MR, Ma T, Galler D, Rankin AP, Williams AB: Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 2004;19:877–884.
10.
Abe M, Okada K, Suzuki M, et al: Comparison of sustained hemodiafiltration with continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury. Artif Organs 2010;34:331–338.
11.
Kron J, Kron S, Wenkel R, et al: Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure. Nephrol Dial Transplant 2012;27:146–152.
12.
Kawanisi H, Akiba T, Masakane I, et al: The standard on bacterial management of fluids for hemodialysis and related therapies from Japanese Society for Dalysis Therapy (JSTD) 2008. Ther Apher Dial 2009;13:161–166.
13.
Canaud B, Bosc JY, Leray-Moragues H, Stec F, Argiles A, Leblanc M, Mion C: On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 2000;15(suppl 1):60–67.
14.
Masakane I, Takemoto Y, Nakai S, et al: Bacteriological water quality in the central dialysis fluid delivery system from the survey of the Japanese Society for Dialysis Therapy. Blood Purif 2009;27(suppl 1):11–16.
15.
Canaud B, Bosc JY, Leray H, et al: On-line haemodiafiltration: state of the art. Nephrol Dial Transplant Suppl 1998;5:3–11.
16.
Pettilä V, Tiula E: Intermittent hemodiafiltration in acute renal failure in critically ill patients. Clin Nephrol 2001;56:324–331.
17.
Laurent I, Adrie C, Vinsonneau C, et al: High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005;46:432–437.
18.
Kawanishi H: On-line hemodiafiltration in critical care. Ther Apher 2002;6:199–203.
19.
Kawanishi H: On-line continuous hemodiafiltration in sepsis. Transfus Apher Sci 2006;35:265–269.
20.
Pass T, Wright R, Sharp B, Harding GB: Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperatures underestimate microbial contamination. Blood Purif 1996;14:136–145.
21.
Arduino MJ, Bland LA, Aguero SM, Favero MS: Effects of incubation time and temperature on microbiologic sampling procedures for hemodialysis fluids. J Clin Microbiol 1991;29:1462–1465.
22.
European Best Practice Guidelines for hemodialysis: Section IV. Dialysis fluid purity. Nephrol Dial Transplant 2002;17(suppl 7): 45–62.
23.
Circulaire n° DHOS/E4/AFSSAPS/DGS/ 2007/52 du 30 janvier 2007 relative aux spécifications techniques et à la sécurité sanitaire de la pratique de l’hémofiltration et de l’hémodiafiltration en ligne dans les établissements de santé.
24.
Pearson FC, Dubczak J, Weary M, Anderson J: Determination of endotoxin levels and their impact on interleukin-1 generation in continuous ambulatory peritoneal dialysis and hemodialysis. Blood Purif 1988;6:207–212.
25.
Le Gall JR, Loirat P, Alperovitch A: Simplified acute physiological score for intensive care patients. Lancet 1983;2:741–743.
26.
Pegues DA, Oettinger CW, Bland LA, et al: A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 1992;3:1002–1007.
27.
Penne EL, Visser L, van den Dorpel MA, et al: Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice. Kidney Int 2009;76:665–672.
28.
Bommer J, Jaber BL: Ultrapure dialysate: facts and myths. Semin Dial 2006;19:115–119.
29.
Schiffl H: High-flux dialyzers, backfiltration, and dialysis fluid quality. Semin Dial 2011;24:1–4.
30.
Vaslaki L, Karátson A, Vörös P, et al: Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration. Nephrol Dial Transplant 2000;15(suppl 1):74–78.
31.
Honore PM, Joannes-Boyau O, Boer W, Collin V, Jennes S: Continuous haemofiltration in 2009: what’s new for clinicians regarding pathophysiology, technique to be privileged and dose to be recommended. In-depth review. Blood Purif 2009;28:135–143.
32.
Kanagasundaram NS, Larive AB, Paganini EP: A preliminary survey of bacterial contamination of the dialysate circuit in continuous veno-venous hemodialysis. Clin Nephrol 2003;59:47–55.
33.
Moore I, Bhat R, Hoenich NA, Kilner AJ, Prabhu M, Orr KE, Kanagasundaram NS: A microbiological survey of bicarbonate-based replacement circuits in continuous veno-venous hemofiltration. Crit Care Med 2009;37:496–500.
34.
Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26–30.
35.
The VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7–20.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.